Site Members can sign up for company wide alerts
Investigation Overview
Mar. 20, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Obagi Medical Products, Inc. (NASDAQ:OMPI) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Obagi Medical Products, Inc. for $19.75 per NASDAQ:OMPI share and the takeover process are unfair to investors in Obagi Medical Products shares. The investig...
You must register (for free) or login to view the entire investigation.